DDInter459 DDInter1610
Cyproheptadine is a potent competitive antagonist of both serotonin and histamine receptors. It is used primarily to treat allergic symptoms, though it is perhaps more notable for its use in appetite stimulation and its off-label use in the treatment of serotonin syndrome.
Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.
Cyproheptadine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tapentadol
Tapentadol {u} (Compound) resembles {v} (Compound) Rivastigmine
Cyproheptadine {u} (Compound) upregulates {v} (Gene) GTPBP8
GTPBP8 {u} (Gene) is downregulated by {v} (Compound) Rivastigmine
Cyproheptadine {u} (Compound) causes {v} (Side Effect) Dizziness
Dizziness {u} (Side Effect) is caused by {v} (Compound) Rivastigmine
Cyproheptadine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tapentadol
Tapentadol {u} (Compound) binds {v} (Gene) CYP2D6
CYP2D6 {u} (Gene) is bound by {v} (Compound) Rivastigmine
Cyproheptadine {u} (Compound) upregulates {v} (Gene) GTPBP8
GTPBP8 {u} (Gene) is regulated by {v} (Gene) UBQLN2
UBQLN2 {u} (Gene) is upregulated by {v} (Compound) Rivastigmine
Cyproheptadine {u} (Compound) causes {v} (Side Effect) Dizziness
Dizziness {u} (Side Effect) is caused by {v} (Compound) Tapentadol
Tapentadol {u} (Compound) resembles {v} (Compound) Rivastigmine
Cyproheptadine {u} (Compound) causes {v} (Side Effect) Pollakiuria
Pollakiuria {u} (Side Effect) is caused by {v} (Compound) Pyridostigmine
Pyridostigmine {u} (Compound) resembles {v} (Compound) Rivastigmine
Cyproheptadine {u} (Compound) resembles {v} (Compound) Metixene
Metixene {u} (Compound) downregulates {v} (Gene) GTPBP8
GTPBP8 {u} (Gene) is downregulated by {v} (Compound) Rivastigmine
Cyproheptadine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tapentadol
Tapentadol {u} (Compound) causes {v} (Side Effect) Pruritus
Pruritus {u} (Side Effect) is caused by {v} (Compound) Rivastigmine
Cyproheptadine {u} (Compound) upregulates {v} (Gene) GTPBP8
GTPBP8 {u} (Gene) regulates {v} (Gene) IFRD2
IFRD2 {u} (Gene) is downregulated by {v} (Compound) Rivastigmine
Cyproheptadine may cause a moderate interaction that could exacerbate diseases when taken with Tapentadol and Tapentadol (Compound) resembles Rivastigmine (Compound)
Cyproheptadine (Compound) upregulates GTPBP8 (Gene) and GTPBP8 (Gene) is downregulated by Rivastigmine (Compound)
Cyproheptadine (Compound) causes Dizziness (Side Effect) and Dizziness (Side Effect) is caused by Rivastigmine (Compound)
Cyproheptadine may cause a moderate interaction that could exacerbate diseases when taken with Tapentadol and Tapentadol (Compound) binds CYP2D6 (Gene) and CYP2D6 (Gene) is bound by Rivastigmine (Compound)
Cyproheptadine (Compound) upregulates GTPBP8 (Gene) and GTPBP8 (Gene) is regulated by UBQLN2 (Gene) and UBQLN2 (Gene) is upregulated by Rivastigmine (Compound)
Cyproheptadine (Compound) causes Dizziness (Side Effect) and Dizziness (Side Effect) is caused by Tapentadol (Compound) and Tapentadol (Compound) resembles Rivastigmine (Compound)
Cyproheptadine (Compound) causes Pollakiuria (Side Effect) and Pollakiuria (Side Effect) is caused by Pyridostigmine (Compound) and Pyridostigmine (Compound) resembles Rivastigmine (Compound)
Cyproheptadine (Compound) resembles Metixene (Compound) and Metixene (Compound) downregulates GTPBP8 (Gene) and GTPBP8 (Gene) is downregulated by Rivastigmine (Compound)
Cyproheptadine may cause a moderate interaction that could exacerbate diseases when taken with Tapentadol and Tapentadol (Compound) causes Pruritus (Side Effect) and Pruritus (Side Effect) is caused by Rivastigmine (Compound)
Cyproheptadine (Compound) upregulates GTPBP8 (Gene) and GTPBP8 (Gene) regulates IFRD2 (Gene) and IFRD2 (Gene) is downregulated by Rivastigmine (Compound)